Merck

Merck

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo

US to buy about 1.7 mln courses of Merck's Covid-19 treatment for $1.2 bln

Molnupiravir is an experimental antiviral therapy Merck is developing with Ridgeback Biotherapeutics for the treatment of Covid-19 patients who are not hospitalised

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo

Merck taps five Indian drugmakers to expand Covid-19 drug production

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid

EU regulator advises against use of Merck's anti-parasite drug for Covid-19

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid

Merck says study shows Covid-19 drug causes quick reduction in virus

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

Merck to help make Johnson & Johnson's Covid-19 vaccine: White House official

File photo of Covid-19 Vaccine/REUTERS

Merck ends Covid vaccine program, cites inferior immune responses

Woman holds vials labelled "Covid-19 Coronavirus Vaccine" over dry ice in this illustration taken, December 5, 2020. REUTERS/Dado Ruvic/Illustration

Merck in supply agreement with US government for its Covid-19 treatment

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo

Drugmaker Merck divests stake in vaccine-maker Moderna

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid

Merck CEO sees human trials for Covid-19 vaccine candidate 'fairly soon'

FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo

EU secures potential Covid-19 drugs from Roche, Germany's Merck